Quest Diagnostics (DGX) Tops Q1 EPS by 5c; offers guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $246.45 -0.4%
Revenue Growth %: +7.8%
Financial Fact:
Total operating costs and expenses: 1.56B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +7.8%
Financial Fact:
Total operating costs and expenses: 1.56B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $2.21, $0.05 better than the analyst estimate of $2.16. Revenue for the quarter came in at $2.65 billion versus the consensus estimate of $2.64 billion.
GUIDANCE:
Quest Diagnostics sees FY2025 EPS of $9.55-$9.80, versus the consensus of $9.69. Quest Diagnostics sees FY2025 revenue of $10.7-10.85 billion, versus the consensus of $10.78 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Leidos wins $85m Air Force contract for aerospace design
- InMed Pharmaceuticals gets Nasdaq equity deficiency notice
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
